Someone searching for "weight loss injections" usually wants to know two things: are these drugs harmful, and what do they cost per month. The internet offers plenty of both extremes: content that presents these medications as miracles, and "stay away" articles written in the language of fear. We will do neither in this article. GLP-1 injections are clinically effective medications; at the same time, they come with side effects, a serious cost dimension, and a structural sustainability problem — weight regain after discontinuation. Below, we summarize the real side effect profile, June 2026 prices, and the alternatives you can discuss with your physician, all based on data.
What Are Weight Loss Injections, and Do They Actually Work?
The drugs popularly known as "weight loss injections" are injectables in the GLP-1 receptor agonist class: semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), and liraglutide (Saxenda). Rybelsus, the tablet form of semaglutide, works through the same mechanism. These medications regulate appetite signals and slow gastric emptying; as a result, they create a feeling of fullness with fewer calories.
The honest starting point is this: these drugs work. In clinical trials, losses of approximately 15-20% of total body weight were reported during the treatment period — a strong result for pharmacological obesity treatment. The answer to the question of "harms" is not that the drug is bad; it is that the side effect profile, the cost, and the post-discontinuation period need to be understood and planned for from the start.
Harms and Side Effects of Weight Loss Injections
Gastrointestinal side effects
The most frequently reported side effects involve the digestive system: nausea, vomiting, constipation, diarrhea, and bloating. These are most pronounced at the start of treatment and during dose escalation steps; in most users they ease over time. That said, a subset of users discontinues treatment because these complaints reduce their quality of life. The side effect experience varies from person to person; adjusting the pace of dose escalation together with a physician often makes the symptoms manageable.
Risk of muscle mass loss
In rapid weight loss, part of the weight lost is not fat but lean tissue. If adequate protein is not consumed and resistance exercise is not performed during GLP-1 treatment, muscle mass loss can become significant — which negatively affects metabolic rate and long-term weight control. This is why drug therapy should be carried out together with a nutrition plan and exercise; the medication alone is not a program.
Less common risks
Conditions such as pancreatitis, gallbladder problems, and pronounced delayed gastric emptying are rare but should be known. These medications are not used during pregnancy and breastfeeding, in people with certain thyroid cancer histories, or in those with a history of pancreatitis. All of this is why "weight loss injections" should not be sourced through social media or used without follow-up: the medication is managed safely through physician evaluation and regular monitoring.
The real structural problem: weight regain after stopping
A topic discussed less than side effects but, according to the data, more decisive, is what happens after the drug is discontinued. A 2026 systematic review published in the BMJ (West et al.; 37 studies, 9,341 participants) reported an average regain of approximately 9.9 kg in the first year after discontinuation in the GLP-1 subgroup — against an average loss of approximately 14.7 kg. According to the same review, roughly half of users stop the medication within 12 months. Similarly, a meta-analysis of 18 randomized controlled trials covering 3,771 patients (EClinicalMedicine 2025) found an average regain of +5.63 kg in the 12 months after the drug was stopped.
These data do not show that the medication has failed; they show that its effect is limited to the period of use. The practical question is this: do you plan to use this drug for years, and if not, what will your exit strategy be?
Further reading: Weight regain after stopping GLP-1: what does the data say? · Clinical evidence
Weight Loss Injection Prices (June 2026)
According to the official medication price list dated June 9, 2026, the approximate amounts in Turkey are as follows:
| Medication | Dose / Package | Approximate monthly cost |
|---|---|---|
| Ozempic | 1 mg pen (~1 month) | ~10,643 TL |
| Wegovy | 1.7 mg pen | ~15,782 TL |
| Wegovy | 2.4 mg pen | ~20,661 TL |
| Mounjaro | 2.5 mg monthly box | ~12,295 TL |
| Mounjaro | 5 mg monthly box | ~16,032 TL |
| Mounjaro | 7.5-10 mg monthly box | ~21,638 TL |
| Mounjaro | 12.5-15 mg monthly box | ~27,244 TL |
| Saxenda | 3-pen box (~6,729 TL); lasts ~18 days at 3 mg/day | ~11,000-13,500 TL |
| Rybelsus | tablet form | ~8,000-12,000 TL |
Three points matter:
- SGK does not pay. GLP-1 medications are not covered by reimbursement for the obesity indication; they are prescribed on a private (non-reimbursed) prescription and paid entirely out of pocket.
- This is not a one-month cost but an ongoing one. Since the effect is limited to the period of use, annual maintenance corresponds to roughly 130,000-260,000 TL.
- Prices are volatile. Drug prices rose during the year through the exchange-rate mechanism; on the other hand, generic semaglutide is expected to arrive in Turkey in the 2026 wave, which could push prices down.
Prices are subject to change; last updated: June 10, 2026.
Further reading: Cost calculator · Gastric balloon prices 2026
Who Is It Suitable For — and Who Isn't It?
GLP-1 therapy typically comes into consideration, with physician evaluation, for people diagnosed with obesity or with weight-related health conditions (such as type 2 diabetes, hypertension, or sleep apnea). You can check your body mass index with the BMI calculator; however, the number alone does not make the decision.
The unsuitable situations are also clear: pregnancy and breastfeeding, certain thyroid cancer histories, prior pancreatitis, and use under age 18. Cosmetic goals such as "losing a few kilos before a wedding" are not an indication for these medications. Injections obtained through social media and used without follow-up are problematic in terms of both side effect management and dosing safety. The decision should be made with a physician who evaluates your weight history, your accompanying conditions, and your budget together.
Alternatives to Weight Loss Injections
The reasons people look for alternatives usually fall into three categories: side effects, the unsustainability of the monthly cost, and the question of "what happens when I stop." An important note: the existence of alternatives does not mean the medications are bad. The question is which tool fits your health status, your goal, and your budget.
Structured lifestyle programs
Programs that combine dietitian follow-up, an exercise plan, and behavior change components are the foundation of every weight loss journey — even when medication or a balloon is used. The loss achieved through lifestyle change alone is generally more limited, and maintaining it requires discipline; but whichever method is chosen, achieving long-term results without this foundation is difficult.
Swallowable gastric balloon program
The swallowable gastric balloon (Allurion) is swallowed in a capsule; no endoscopy or anesthesia is required for placement. The balloon remains in the stomach for approximately 16 weeks, then deflates on its own and is passed naturally. The method is not a standalone tool but part of a program that includes nutrition and behavior change follow-up.
The data: in a clinical study covering 1,770 patients (Ienca 2020), the program average was 14.9% total body weight loss — close to the loss seen during drug treatment, below the upper range of the medications. In a follow-up study of 522 patients (Caballero), 95% of patients maintained their weight loss 1 year after the end of the program. On the regulatory side, the system received PMA approval from the FDA in February 2026; its TİTCK (Turkish Medicines and Medical Devices Agency) registration is current (the January 2025 suspension was officially lifted in February 2025), and it is offered at more than 60 authorized centers in Turkey.
The cost structure is also different: instead of monthly maintenance, there is a one-time program fee. Rather than being a "rival" to the injection, the balloon is positioned as an exit strategy for those planning to stop the medication, or as a behavior-change-focused starting point for those who do not want medication. Results vary from person to person.
Combined and sequential approaches
Protocols using the medication and the balloon together or sequentially are being researched. A preliminary study of 76 patients combining low-dose GLP-1/GIP with the Allurion balloon reported 23% total body weight loss; this result is at the press release stage and has not yet been confirmed in a peer-reviewed publication. The early literature also offers signals supporting combination approaches. This option is worth discussing with a physician, particularly for those who want to keep the medication dose low or taper off the drug gradually.
Further reading: GLP-1 + gastric balloon combination: the evidence · Gastric balloon or GLP-1? The 2026 comparison · Swallowable gastric balloon guide
When Deciding: Three Questions
You can distill everything you have read about weight loss injections into three questions:
- Can I tolerate the side effects? Manageable for most people; but you only learn this under physician follow-up, with gradual dosing.
- Can my budget handle an ongoing cost? An out-of-pocket expense of 130,000-260,000 TL per year is, for most households, the decision itself.
- What is my exit plan? The data show that stopping without a plan brings back a significant portion of the loss. Medication, a balloon program, a lifestyle foundation, or their sequential use — the strategy should be set from the start.
The answers to these questions are individual. To evaluate your weight history and your options, you can consult an authorized center near you.
This content is for general informational purposes only and does not constitute medical advice. Before deciding on weight loss injections, a gastric balloon, or any weight loss method, always consult your physician.
Clinical Sources
Related Articles
Gastric Balloon or GLP-1? Which Is More Effective in 2026?
Gastric balloon vs GLP-1 receptor agonists comparison: efficacy, sustainability, price, and side effects. A 2026 guide based on clinical data.
Gastric Balloon + GLP-1 Combination Therapy: Efficacy and Protocol
A new-generation protocol combining the gastric balloon with GLP-1 receptor agonists: mechanism, preliminary clinical data, advantages, and patient guidance.
What Happens When You Stop Ozempic and GLP-1? Weight Regain Data
Do you regain weight after stopping GLP-1 drugs like Ozempic, Wegovy, and Mounjaro? The data, based on an 18-RCT meta-analysis and a BMJ 2026 review.
Related Pages
Which method is right for you?
Let our specialist physicians evaluate you free of charge.
Free Pre-Assessment →